Learn about CVE-2022-47376, a vulnerability in Alaris Infusion Central software versions 1.1 to 1.3.2. Discover the impact, technical details, and mitigation steps.
This article provides an overview of CVE-2022-47376, a vulnerability found in the Alaris Infusion Central software. Learn about the impact, technical details, and how to mitigate this security issue.
Understanding CVE-2022-47376
CVE-2022-47376 is a security vulnerability identified in the Alaris Infusion Central software, versions 1.1 to 1.3.2. The presence of a recoverable password after installation poses a risk to system security.
What is CVE-2022-47376?
The Alaris Infusion Central software, in versions 1.1 to 1.3.2, may contain a recoverable password post-installation. While patient health data is not stored in the database, some site installations may choose to store personal data, making it crucial to address this vulnerability.
The Impact of CVE-2022-47376
The vulnerability exposes a recoverable password in the Alaris Infusion Central software, potentially leading to unauthorized access and data exposure. Although patient health data is not at risk, stored personal data could be compromised.
Technical Details of CVE-2022-47376
The following section outlines key technical details of the CVE-2022-47376 vulnerability.
Vulnerability Description
The issue arises from the presence of a recoverable password in versions 1.1 to 1.3.2 of the Alaris Infusion Central software, allowing unauthorized access and data exposure.
Affected Systems and Versions
Exploitation Mechanism
The vulnerability can be exploited by attackers with access to the recoverable password to gain unauthorized entry into the Alaris Infusion Central software.
Mitigation and Prevention
Protect your systems from CVE-2022-47376 with the following mitigation strategies and best practices.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates
Stay informed about security updates and patches released by the vendor to address the recoverable password vulnerability in the Alaris Infusion Central software.